RIPK3 and cardiomyopathy: Furthermore, RIPK3 depletion ameliorates cardiomyopathy in mdx mice, suggesting that necroptosis inhibition may have multiorgan benefits in DMD, tackling cell degeneration together with locomotor, respiratory and heart muscles [18,186].